Suchen

Filter löschen
Filtern nach: Platform Presentation No thank you Filter Platform Presentation: No thank you entfernen Study Program Molecular Medicine Study Program (MolMed) Filter Study Program: Molecular Medicine Study Program (MolMed) entfernen

Suchergebnisse

  • PCSK9 Inhibition Enhances Efficacy of Vemurafenib in Delaying Melanoma Tumor Growth

    Beschreibung: Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary...
    Datum erstellt: August 1-2, 2024

  • Beta-blocker use and hematopoietic stem cell transplant outcomes

    Beschreibung: Background: While hematopoietic stem cell transplantation (HSCT) is an effective treatment for hematological malignancies, it is associated with several potential complications. Recent studies have associated beta-blocker (BB) use in critical care...
    Datum erstellt: August 1-2, 2024